Why is ANG Lifesciences falling/rising?

As of 07-Jul, ANG Lifesciences India Ltd's stock price is currently at Rs 33.81, reflecting an increase of Rs 1.61 or 5.0%. The stock has shown strong performance recently, gaining 15.75% over the last three days and outperforming its sector by 5.08% today. However, despite this short-term gain, the company has reported significant operating losses and has a high Debt to EBITDA ratio of 5.83 times, indicating a weak long-term fundamental strength. The company has faced negative results for the last 12 consecutive quarters, with net sales falling by 55.55% and a negative return on equity, which raises concerns about its financial health and sustainability.
In the broader market context, ANG Lifesciences has outperformed the Sensex in the short term, with a 20.75% increase over the past week compared to a slight decline of 0.20% for the benchmark. However, the stock has consistently underperformed over longer periods, with a year-to-date decline of 24.35% against a 6.79% gain for the Sensex. The high percentage of pledged promoter shares (44.88%) adds to the risk, particularly in a falling market, which could exert additional downward pressure on the stock price. Overall, while there are short-term gains, the long-term outlook remains challenging due to the company's financial difficulties and historical underperformance.